- Home
- LPCN vs MODV Comparison
LPCN vs MODV Comparison
Compare LPCN & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- MODV
- Stock Information
- Founded
- LPCN 1997
- MODV 1996
- Country
- LPCN United States
- MODV United States
- Employees
- LPCN N/A
- MODV N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- LPCN Health Care
- MODV Consumer Discretionary
- Exchange
- LPCN Nasdaq
- MODV Nasdaq
- Market Cap
- LPCN 16.1M
- MODV 16.1M
- IPO Year
- LPCN N/A
- MODV N/A
- Fundamental
- Price
- LPCN $3.40
- MODV $1.12
- Analyst Decision
- LPCN Strong Buy
- MODV Buy
- Analyst Count
- LPCN 1
- MODV 4
- Target Price
- LPCN $10.00
- MODV $8.38
- AVG Volume (30 Days)
- LPCN 10.5K
- MODV 494.3K
- Earning Date
- LPCN 05-08-2025
- MODV 05-08-2025
- Dividend Yield
- LPCN N/A
- MODV N/A
- EPS Growth
- LPCN N/A
- MODV N/A
- EPS
- LPCN N/A
- MODV N/A
- Revenue
- LPCN $3,674,834.00
- MODV $2,787,586,000.00
- Revenue This Year
- LPCN N/A
- MODV N/A
- Revenue Next Year
- LPCN N/A
- MODV $5.64
- P/E Ratio
- LPCN N/A
- MODV N/A
- Revenue Growth
- LPCN N/A
- MODV 1.32
- 52 Week Low
- LPCN $2.75
- MODV $0.96
- 52 Week High
- LPCN $11.79
- MODV $32.82
- Technical
- Relative Strength Index (RSI)
- LPCN 49.75
- MODV 37.48
- Support Level
- LPCN $3.12
- MODV $1.28
- Resistance Level
- LPCN $3.60
- MODV $1.54
- Average True Range (ATR)
- LPCN 0.23
- MODV 0.21
- MACD
- LPCN 0.01
- MODV 0.06
- Stochastic Oscillator
- LPCN 40.12
- MODV 19.26
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.